Novartis owns U.S. Patent No. 9,187,405 relating to methods of treating relapsing-remitting multiple sclerosis (RRMS) using the immunosuppressant fingolimod, and markets a drug under the brand name Gilenya. HEC Pharm…
Read More
Contact Us
P.(631) 501-5700
F.(631) 501-3526